Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Here’s What Happened

Target Healthcare REIT (LON:THRLGet Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 110 and last traded at GBX 106.36, with a volume of 1300578 shares trading hands. The stock had previously closed at GBX 107.60.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, Target Healthcare REIT currently has an average rating of “Hold” and a consensus target price of GBX 101.

Get Our Latest Report on THRL

Target Healthcare REIT Price Performance

The firm’s fifty day moving average price is GBX 103.37 and its 200-day moving average price is GBX 100.87. The firm has a market capitalization of £660.24 million, a P/E ratio of 8.47, a PEG ratio of 1.48 and a beta of 0.69.

Target Healthcare REIT (LON:THRLGet Free Report) last posted its quarterly earnings data on Wednesday, March 18th. The company reported GBX 3.38 earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. Analysts expect that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Featured Stories

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.